Family History of Coronary Heart Disease and Hemostatic Variables in Middle-Aged Adults

Summary

Individuals with a family history of coronary heart disease (CHD) may be predisposed to atherothrombosis. To investigate this hypothesis, a family CHD risk score was computed for approximately 13,000 men and women aged 45 to 64; hemostatic variables (fibrinogen, factor VIIc, factor VIIIc, von Willebrand factor, antithrombin III, protein C) were also measured in plasma. After adjustment for age and ethnicity, there was a statistically significant, positive association between the family risk score and four of the six hemostatic variables (fibrinogen, factor VIIc, factor VIIIc, von Willebrand factor) in women and all six hemostatic variables in men. In general, these associations were weak and substantially attenuated after adjustment for constitutional, lifestyle, and biochemical covariates. These results indicate that mean levels of selected hemostatic variables, like traditional CHD risk factors, are higher in individuals with a family history of heart disease.

• References

• 1 Marenberg M, Risch N, Berkman LF, Floderus B, de FaireU. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041-1046
• 2 King M-C, Lee GM, Spinner NB, Thomson G, Wrensch MR. Genetic epidemiology. Ann Rev Public Health 1984; 5: 1-52
• 3 Perkins KA. Family history of coronary heart disease: is it an independent risk factor?. Am J Epidemiol 1986; 124: 182-194
• 4 Snowden CB, McNamara PM, Garrison RJ, Feinleib M, Kannel WB, Epstein FH. Predicting coronary heart disease in siblings – a multivariate assessment: The Framingham Heart Study. Am J Epidemiol 1982; 115: 217-222
• 5 Barrett-Connor E, Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984; 69: 1065-1069
• 6 Burke GL, Savage PJ, Sprafka JM, Selby JV, Jacobs DR, Perkins LL, Roseman JM, Hughes GH, Fabsitz RR. Relation of risk factor levels in young adulthood to parental history of disease: The CARDIA Study. Circulation 1991; 84: 1176-1187
• 7 Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F, De BackerG. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects: The EARS Study. Circulation 1994; 89: 1967-1973
• 8 Jorde LB, Williams RR. Relation between family history of coronary artery disease and coronary risk variables. Am J Cardiol 1988; 62: 708-713
• 9 Levine RS, Hennekens CH, Rosner B, Gourley J, Gelband H, Jesse MJ. Cardiovascular risk factors among children of men with premature myocardial infarction. Pub Health Rep 1981; 96: 58-60
• 10 Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986; 123: 48-58
• 11 Khaw K, Barrett-Connor E. Family history of heart attack: a modifiable risk factor?. Circulation 1986; 74: 239-244
• 12 Kukita H, Hiwada K, Kokubu T. Serum apoliprotein A-I, A-II, and B levels and their discriminative values in relatives of patients with coronary artery disease. Atherosclerosis 1984; 51: 261-267
• 13 The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702
• 14 Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, Rao DC, Sprafka JM. Williams R for the NHLBI Family Heart Study Investigators The NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996; 143: 1219-1228
• 15 Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study. I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989; 61: 15-19
• 16 Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen Y-L. Shortterm intra-individual variability in hemostasis factors: the ARIC study. Ann Epidemiol 1992; 02: 723-733
• 17 Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942
• 18 Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993; 328: 1069-1075
• 19 Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Chem Clin Biochem 1984; 22: 165-174
• 20 Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075-1080
• 21 Wamick GR, Benderson JM, Albers JJ. Quantitation of high-density lipoprotein subclasses after separation by dextran sulfate and MG²⁺precipitation. Clin Chem 1982; 28: 1574 (abst.)
• 22 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
• 23 ARIC: Atherosclerosis Risk in Communities study: manual 8: lipid and lipoprotein determinations. Chapel Hill, NC: National Heart, Lung, and Blood Institute; 1987
• 24 Rose GA, Blackburn H, Gillum RF, Prineas RJ. eds Cardiovascular survey methods. 02. ^nded World Health Organization monograph series no. 56. Geneva: World Health Organization; 1982
• 25 Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chron Dis 1986; 39: 809-821
• 26 U.S. National Heart, Lung, and Blood Institute. Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Section 34. Framingham Heart Study, 30-Year Follow-up. NIH Publication No. 872703, NTIS PB 87-1774-99. 1987
• 27 SAS Institute Inc., SAS/STAT® User’s Guide, Version 6, Fourth Edition. Volume 02. Cary, NC: SAS Institute Inc; 1989
• 28 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
• 29 Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380-385
• 30 Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Wu KK. Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 762-767
• 31 Conlan MG, Folsom AR, Finch A, Davis CE, Marcucci G, Sorlie P, Wu KK. for the Atherosclerosis Risk in Communities (ARIC) Study Investigators Antithrombin III: associations with age, race, sex, and cardiovascular risk factors. Thromb Haemost 1994; 72: 551-556
• 32 Hopkins PN, Williams RR, Hunt SC. Magnified risks from cigarette smoking for coronary prone families in Utah. West J Med 1984; 141: 196-202
• 33 Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987; 02: 986-988
• 34 Green F, Hamsten A, Blomback M, Humphries S. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70 (06) 915-920
• 35 Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
• 36 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 02: 533-537
• 37 Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease – The Framingham Study. JAMA 1987; 258: 1183-1186
• 38 Reed T, Tracy RP, Fabsitz RR. Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study. Clin Genet 1994; 45: 71-77
• 39 Berg K, Kierulf P. DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet 1989; 36: 229-235
• 40 Hamsten A, Iselius L, de FaireU, Blombäck M. Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 1987; 02: 988-991
• 41 Friedlander Y, Elkana Y, Sinnreich R, Kark JD. Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study. Am J Hum Genet 1995; 56: 1194-1206
• 42 Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, Humphries SE. Variation in the promoter region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65: 487-490
• 43 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546
• 44 Bara L, Nicaud V, Tiret L, Cambien F, Samama MM. on behalf of the EARS group. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIc, and PAI-1 in European offspring – the EARS study. Thromb Haemost 1994; 71: 434-440
• 45 Lee AJ, Lowe GD, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993; 338-342
• 46 Folsom AR, Qamhieh HT, Flack JM, Hilner JE, Liu K, Howard BV, Tracy RP. Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Epidemiol 1993; 138: 1023-1036
• 47 Sanchez-Bayle M, Cocho P, Baeza J, Vila S. and the Nino Jesus Group Fibrinogen as a cardiovascular risk factor in Spanish children and adolescents. Am Heart J 1993; 126: 322-326
• 48 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 1989; 14: 941-946
• 49 Hoffman CJ, Bums P, Lawson WE, Katz JP, Miller RH, Hultin MB. Plasma fibrinogen level is not elevated in young adults from families with premature ischemic heart disease. Arterioscler Thromb 1993; 13: 800-803
• 50 Bums P, Hoffman CJ, Katz JP, Miller RH, Lawson WE, Hultin MB. Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease. J Lab Clin Med 1993; 122: 720-727
• 51 Folsom AR, Wu KK, Shahar E, Davis CE. for the Atherosclerosis Risk in Communities (ARIC) Study investigators Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829-1836
• 52 Miller GJ, Stirling Y, Esnouf MP, Heinrich J, van deLooJ, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, Imeson JD, Cooper JA, Finch A. Factor VH-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48